EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen

Ya-Lin Huang, Cristian De Gregorio iD, Verónica Silva, Álvaro A Elorza, Patricio Léniz, Víctor Aliaga-Tobar, Vinicius Maracaja-Coutinho iD, Mauricio Budini iD, Fernando Ezquer iD, Marcelo Ezquer

Cells · 2023

DOI: 10.3390/cells12040636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Ya-Lin Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Medicina Regenerativa, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Sa…. Hauptthemen laut MEDLINE: Amiodarone, Mesenchymal Stem Cells, Fatty Liver, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FONDECYT REGULAR-ANID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced liver injury (DILI) is one of the leading causes of acute liver injury. While many factors may contribute to the susceptibility to DILI, obese patients with hepatic steatosis are particularly prone to suffer DILI. The secretome derived from mesenchymal stem cell has been shown to have hepatoprotective effects in diverse in vitro and in vivo models. In this study, we evaluate whether MSC secretome could improve DILI mediated by amiodarone (AMI) or tamoxifen (TMX). Hepatic HepG2 and HepaRG cells were incubated with AMI or TMX, alone or with the secretome of MSCs obtained from human adipose tissue. These studies demonstrate that coincubation of AMI or TMX with MSC secretome increases cell viability, prevents the activation of apoptosis pathways, and stimulates the expression of priming phase genes, leading to higher proliferation rates. As proof of concept, in a C57BL/6 mouse model of hepatic steatosis and chronic exposure to AMI, the MSC secretome was administered endovenously. In this study, liver injury was significantly attenuated, with a decrease in cell infiltration and stimulation of the regenerative response. The present results indicate that MSC secretome administration has the potential to be an adjunctive cell-free therapy to prevent liver failure derived from DILI caused by TMX or AMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmiodaroneMesenchymal Stem CellsFatty LiverChemical and Drug Induced Liver InjuryMiceAnimalsHumansTamoxifenSecretomeMice, Inbred C57BLImmunologic Factors

Stichwörter der Autor:innen

amiodaronecell free therapydrug-induced liver injuryhepatic regenerationtamoxifen

Substanzen

TamoxifenAmiodaroneImmunologic Factors

Autor:innen und Institutionen

  • Centro de Medicina Regenerativa, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Santiago 7610658, Chile.
  • Instituto de Ciencias Biomédicas, Facultad de Medicina y Ciencias de la Vida, Universidad Andres Bello, Santiago 7610658, Chile.
  • Unidad de Cirugía Plástica, Reparadora y Estética, Clínica Alemana, Santiago 7610658, Chile.
  • Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 7610658, Chile.
  • Centro de Modelamiento Molecular, Biofísica y Bioinformática (CM2B2), Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 7610658, Chile.
  • Laboratorio de Bioingeniería, Instituto de Ciencias de la Ingeniería, Universidad de O'Higgins, Rancagua 7610658, Chile.

ORCID-Profile: Cristian De Gregorio, Vinicius Maracaja-Coutinho, Mauricio Budini, Fernando Ezquer

Förderung

  • FONDECYT REGULAR-ANID

Zitieren

APA

Huang, Y. L., De Gregorio, C., Silva, V., Elorza, Á. A., Léniz, P., Aliaga-Tobar, V., Maracaja-Coutinho, V., Budini, M., Ezquer, F., & Ezquer, M. (2023). Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen. Cells. https://doi.org/10.3390/cells12040636

Vancouver

Huang YL, De Gregorio C, Silva V, Elorza ÁA, Léniz P, Aliaga-Tobar V, et al. Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen. Cells. 2023. doi:10.3390/cells12040636

BibTeX
@article{Huang2023,
  author = {Huang, Ya-Lin and De Gregorio, Cristian and Silva, Verónica and Elorza, Álvaro A and Léniz, Patricio and Aliaga-Tobar, Víctor and Maracaja-Coutinho, Vinicius and Budini, Mauricio and Ezquer, Fernando and Ezquer, Marcelo},
  title = {Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12040636}
}
Kostenlos starten →